CNS Pharmaceuticals Sees Surge Amid Strategic Developments
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) has captured investor attention with a dramatic shift in its stock performance. After a steep 12.9% decline during Friday’s regular trading session, the company’s shares rebounded significantly in premarket trading on Monday, surging by 49%. This upswing not only erased the previous losses but also propelled the stock from $0.25 […]
CNS Pharmaceuticals Sees Surge Amid Strategic Developments Read More »